# Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19

> **NCT04496141** · — · COMPLETED · sponsor: **Hong Kong Sanatorium & Hospital** · enrollment: 70 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** SARS-CoV-2 antibody immunoassays

## Key facts

- **NCT ID:** NCT04496141
- **Lead sponsor:** Hong Kong Sanatorium & Hospital
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-27
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-08-31
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04496141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04496141, "Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04496141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*